- Home
- SLGL vs GEG Comparison
SLGL vs GEG Comparison
Compare SLGL & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- GEG
- Stock Information
- Founded
- SLGL 1997
- GEG 1994
- Country
- SLGL Israel
- GEG United States
- Employees
- SLGL N/A
- GEG N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- SLGL Health Care
- GEG Technology
- Exchange
- SLGL Nasdaq
- GEG Nasdaq
- Market Cap
- SLGL 69.1M
- GEG 72.4M
- IPO Year
- SLGL 2018
- GEG N/A
- Fundamental
- Price
- SLGL $26.57
- GEG $2.80
- Analyst Decision
- SLGL
- GEG
- Analyst Count
- SLGL 0
- GEG 0
- Target Price
- SLGL N/A
- GEG N/A
- AVG Volume (30 Days)
- SLGL 32.9K
- GEG 902.9K
- Earning Date
- SLGL 11-14-2025
- GEG 11-10-2025
- Dividend Yield
- SLGL N/A
- GEG N/A
- EPS Growth
- SLGL N/A
- GEG N/A
- EPS
- SLGL N/A
- GEG 0.38
- Revenue
- SLGL $23,931,000.00
- GEG $16,315,999.00
- Revenue This Year
- SLGL N/A
- GEG N/A
- Revenue Next Year
- SLGL $31.17
- GEG N/A
- P/E Ratio
- SLGL N/A
- GEG $7.47
- Revenue Growth
- SLGL 264.86
- GEG N/A
- 52 Week Low
- SLGL $4.01
- GEG $1.70
- 52 Week High
- SLGL $30.00
- GEG $3.51
- Technical
- Relative Strength Index (RSI)
- SLGL 65.38
- GEG 58.00
- Support Level
- SLGL $23.15
- GEG $2.58
- Resistance Level
- SLGL $24.85
- GEG $2.99
- Average True Range (ATR)
- SLGL 2.32
- GEG 0.25
- MACD
- SLGL -0.41
- GEG -0.01
- Stochastic Oscillator
- SLGL 61.43
- GEG 42.28
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.